시장보고서
상품코드
1687622

말초 인터벤션 시장 규모, 점유율, 성장 분석 : 개입 유형별, 디바이스 유형별, 적응증별, 기술별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Peripheral Interventions Market Size, Share, and Growth Analysis, By Intervention Type (Atherectomy, Stent Implantation), By Device Type (Catheters, Stents), By Indication, By Technology, By End User, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 219 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

말초 인터벤션 시장 규모는 2023년에 102억 달러로 평가되며, 2024년 111억 3,000만 달러에서 2032년에는 223억 4,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 9.1%로 성장할 전망입니다.

고혈압, 당뇨병, 비만, 흡연, 고탄수화물 식단 등의 요인으로 인해 심혈관 질환(CVD)의 발병률이 증가하면서 말초 중재시술에 대한 수요가 크게 증가하고 있습니다. 이러한 건강 문제를 해결하기 위해 전 세계에서 카테터 검사실(카테터랩) 증가는 특히 신흥 시장에서 두드러지게 나타나고 있으며, 이에 따라 이 분야를 전문으로 하는 의료 종사자의 수도 증가하고 있습니다. 카테터랩은 CVD 진단과 치료에 필수적인 존재가 되고 있으며, 특히 개발도상국에서는 그 존재감이 확대되고 있습니다. 심혈관 중재시술뿐만 아니라 다양한 시술을 지원하는 하이브리드 실험실의 등장은 업계의 기술 혁신을 강조하고 있습니다. 예를 들어 인도의 카테터 연구소는 혈관 성형술의 급증과 함께 최근 두 배 이상 증가했으며, 그 결과 전 세계 의료 지출을 증가시켜 말초 중재시술 서비스의 추가 성장이 기대되고 있습니다.

목차

서론

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장의 전제조건과 제한

개요

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter의 산업 분석

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁의 정도
  • 주요 투자 기회
  • 시장 에코시스템
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석

말초 인터벤션 시장 규모 : 개입 유형별 & CAGR(2025-2032)

  • 시장 개요
  • 죽종절제술
  • 스텐트 유치술
  • 혈관성형술
  • 혈전 제거술
  • 색전술

말초 인터벤션 시장 규모 : 디바이스 유형별 & CAGR(2025-2032)

  • 시장 개요
  • 카테터
  • 스텐트
  • 가이드와이어
  • 풍선
  • 색전코일

말초 인터벤션 시장 규모 : 적응증별 & CAGR(2025-2032)

  • 시장 개요
  • 관상동맥 질환
  • 뇌졸중
  • 말초동맥 질환
  • 신장 동맥 협착
  • 경동맥협착증

말초 인터벤션 시장 규모 : 기술별 & CAGR(2025-2032)

  • 시장 개요
  • 약제용출스텐트
  • 풍선 확장형 스텐트
  • 자기 확장형 스텐트
  • 회전식 아테렉토미
  • 방향성 아테렉토미

말초 인터벤션 시장 규모 : 최종사용자별 & CAGR(2025-2032)

  • 시장 개요
  • 병원
  • 외래 수술 센터
  • 클리닉
  • 조사기관

말초 인터벤션 시장 규모 : 지역별 & CAGR(2025-2032)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽 지역
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카 지역
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 최근 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업의 기업 개요
    • 기업의 상세
    • 제품 포트폴리오 분석
    • 기업의 부문별 점유율 분석
    • 매출의 전년대비 비교(2022-2024)

주요 기업 개요

  • Medtronic plc(Ireland)
  • Abbott Laboratories(USA)
  • Boston Scientific Corporation(USA)
  • Becton, Dickinson and Company(BD)(USA)
  • Philips(Netherlands)
  • Terumo Corporation(Japan)
  • Cook Medical(USA)
  • Cardinal Health, Inc.(USA)
  • B. Braun Melsungen AG(Germany)
  • Getinge AB(Sweden)
  • Merit Medical Systems, Inc.(USA)
  • BIOTRONIK SE & Co. KG(Germany)
  • Endologix, Inc.(USA)
  • ArtVentive Medical Group, Inc.(USA)
  • Inari Medical, Inc.(USA)
  • Bentley InnoMed GmbH(Germany)
  • Gore Medical(USA)
  • MicroPort Scientific Corporation(China)

결론과 제안

KSA 25.04.24

Peripheral Interventions Market size was valued at USD 10.2 billion in 2023 and is poised to grow from USD 11.13 billion in 2024 to USD 22.34 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The rising incidence of cardiovascular disorders (CVD) is significantly driving demand for peripheral interventions, fueled by factors like hypertension, diabetes, obesity, smoking, and high-carb diets. To address this health issue, there is a notable increase in catheterization laboratories (cath labs) globally, particularly in emerging markets, accompanied by a growing number of healthcare professionals specializing in this field. Cath labs are becoming essential for diagnosing and treating CVD, and their presence is expanding, especially in developing nations. The advent of hybrid labs, which support various procedures beyond cardiovascular interventions, highlights industry innovation. For instance, India's cath labs have more than doubled recently, coinciding with a surge in angioplasties, thereby boosting global healthcare spending and anticipating further growth in peripheral intervention services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Interventions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Interventions Market Segments Analysis

Global Peripheral Interventions Market is segmented by Intervention Type, Device Type, Indication, Technology, End User and region. Based on Intervention Type, the market is segmented into Atherectomy, Stent Implantation, Angioplasty, Thrombectomy and Embolization. Based on Device Type, the market is segmented into Catheters, Stents, Guide Wires, Balloons and Embolic Coils. Based on Indication, the market is segmented into Coronary Artery Disease, Stroke, Peripheral Arterial Disease, Renal Artery Stenosis and Carotid Artery Stenosis. Based on Technology, the market is segmented into Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy and Directional Atherectomy. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Interventions Market

The increasing prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD), is a significant factor fueling the demand for peripheral intervention solutions. This surge in cases of cardiovascular conditions can largely be linked to risk factors such as hypertension, diabetes, obesity, and a lack of physical activity. As more individuals face these health challenges, there is an urgent need for effective peripheral therapies that address these issues. Consequently, healthcare providers and manufacturers are responding to this growing demand by developing and offering innovative treatment options tailored to manage and mitigate the effects of these cardiovascular disorders.

Restraints in the Peripheral Interventions Market

The Peripheral Interventions market faces significant limitations due to the high costs associated with these treatments, which can be a barrier for many individuals seeking care. In particular, those living in developed regions may find that expensive healthcare options hinder their access to necessary procedures. The financial strain imposed by these interventions can deter patients from pursuing them, ultimately affecting the overall growth and accessibility of the market. Consequently, the high cost of peripheral interventions remains a critical restraint that impacts patient choices and the market's expansion potential in various geographic areas.

Market Trends of the Peripheral Interventions Market

The Peripheral Interventions market is experiencing a significant trend towards the establishment of heterogeneous catheterization labs that integrate various invasive interventional treatments, including cardiac, vascular, neurological, and electrophysiological procedures. These hybrid facilities are gaining traction due to their flexibility, which allows healthcare providers to streamline operations and enhance patient outcomes by combining different specialties under one roof. This trend is driven by the demand for minimally invasive treatment options and the need for efficient patient management, propelling market growth. As technology advances and the focus shifts to personalized care, the hybridization of catheterization labs is set to revolutionize the landscape of peripheral interventions.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Peripheral Interventions Market Size by Intervention Type & CAGR (2025-2032)

  • Market Overview
  • Atherectomy
  • Stent Implantation
  • Angioplasty
  • Thrombectomy
  • Embolization

Global Peripheral Interventions Market Size by Device Type & CAGR (2025-2032)

  • Market Overview
  • Catheters
  • Stents
  • Guide Wires
  • Balloons
  • Embolic Coils

Global Peripheral Interventions Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Coronary Artery Disease
  • Stroke
  • Peripheral Arterial Disease
  • Renal Artery Stenosis
  • Carotid Artery Stenosis

Global Peripheral Interventions Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Drug-Eluting Stents
  • Balloon-Expandable Stents
  • Self-Expanding Stents
  • Rotational Atherectomy
  • Directional Atherectomy

Global Peripheral Interventions Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Research Institutes

Global Peripheral Interventions Market Size & CAGR (2025-2032)

  • North America (Intervention Type, Device Type, Indication, Technology, End User)
    • US
    • Canada
  • Europe (Intervention Type, Device Type, Indication, Technology, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Intervention Type, Device Type, Indication, Technology, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Intervention Type, Device Type, Indication, Technology, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Intervention Type, Device Type, Indication, Technology, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endologix, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ArtVentive Medical Group, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inari Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bentley InnoMed GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gore Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제